Beryl Capital Management’s The Oncology Institute Warrant TOIIW Stock Holding History
Bought
Maintained
Sold
Other funds holding TOIIW
DM
UOC
RCM
DKCM
KC
QGA
GCL
Beryl Capital Management's TOIIW Position: Q2 2021 in Review
Beryl Capital Management sold out of The Oncology Institute Warrant (TOIIW) in Q2 2021, closing a stake of 24,481 shares — an estimated $33K sold.
Beryl Capital Management first reported a position in TOIIW in Q1 2021 and held it in 1 quarter. The position peaked at $33K in Q1 2021. 26 funds tracked by Wall St. Rank hold TOIIW as of Q2 2021.
- Beryl Capital Management reported no remaining The Oncology Institute Warrant position as of Q2 2021 after selling out during the quarter.
- Beryl Capital Management sold 24,481 The Oncology Institute Warrant shares in Q2 2021, an estimated $33K.
- Beryl Capital Management first reported a position in The Oncology Institute Warrant in Q1 2021 and held it in 1 quarter.
- Beryl Capital Management's The Oncology Institute Warrant position peaked at $33K in Q1 2021.
- 26 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q2 2021.
Based on Beryl Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.